Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of SKYCellflu Quadrivalent in Children Aged 6-35 Months
NCT03020628Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Oct 2016
- Primary completion
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of NBP607-V in influenza, sponsored by SK Chemicals. Started Oct 2016; status: completed.
02
Drugs
NBP607-V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03020628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020628.